Orbimed Advisors LLC insider trades
Open-market stock purchases and sales by Orbimed Advisors LLC, Director, 10% Owner at ADARx Pharmaceuticals, Inc, from SEC Form 4 filings since Feb 19, 2019.
Track record: 55% of 105 scored buys are up 5% or more since purchase, averaging +37%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc | Bought (not open market) | — |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc | Bought (not open market) | — |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc | Bought (not open market) | — |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc | Bought (not open market) | — |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc | Bought | $5.1M |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc | Bought (not open market) | — |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc | Bought (not open market) | — |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc | Bought (not open market) | — |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc | Bought (not open market) | — |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc | Bought | $1M |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc | Bought | $10M |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc | Bought (not open market) | — |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc | Bought (not open market) | — |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc | Bought (not open market) | — |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc | Bought (not open market) | — |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc | Bought (not open market) | — |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc | Bought (not open market) | — |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc | Bought (not open market) | — |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc | Bought (not open market) | — |
| Sep 21, 2026 | ETRA Electra Therapeutics, Inc | Bought (not open market) | — |
| Sep 21, 2026 | ETRA Electra Therapeutics, Inc | Bought (not open market) | — |
| Sep 21, 2026 | ETRA Electra Therapeutics, Inc | Bought (not open market) | — |
| Sep 21, 2026 | ETRA Electra Therapeutics, Inc | Bought | $5M |
| Sep 21, 2026 | ETRA Electra Therapeutics, Inc | Bought (not open market) | — |
| Sep 21, 2026 | ETRA Electra Therapeutics, Inc | Bought | $15M |
Companies traded
- ADRX ADARx Pharmaceuticals, Inc: 3 buys, last Sep 28, 2026
- ETRA Electra Therapeutics, Inc: 2 buys, last Sep 21, 2026
- BLSM BlossomHill Therapeutics, Inc: 1 buy, last Aug 10, 2026
- BRVE Braveheart Bio, Inc: 2 buys, last Aug 7, 2026
- SCTX Scribe Therapeutics, Inc: 1 buy, last Jul 27, 2026
- SION Sionna Therapeutics, Inc: 1 buy, 20 sales, last Jul 7, 2026
- ELVN Enliven Therapeutics, Inc: 8 sales, last Jun 22, 2026
- STTK Shattuck Labs, Inc: 8 buys, last Jun 11, 2026
- QTTB Q32 Bio Inc: 2 buys, last May 28, 2026
- PRLD Prelude Therapeutics Inc: 8 buys, last Apr 21, 2026
- TRAW Traws Pharma, Inc: 3 buys, last Apr 16, 2026
- IMA ImageneBio, Inc: 2 buys, last Apr 14, 2026
Get free alerts when Orbimed Advisors LLC files a new trade →